Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 82
Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
Kadhim Hayawi, Sakib Shahriar, Mohamed Adel Serhani, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1305-1305
Open Access | Times Cited: 58
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 49
Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial
Anxo Fernández‐Ferreiro, Francisco Javier Formigo Couceiro, Roi Veiga-Gutierrez, et al.
Nutrients (2022) Vol. 14, Iss. 1, pp. 228-228
Open Access | Times Cited: 29
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
Yot Teerawattananon, Thunyarat Anothaisintawee, Chatkamol Pheerapanyawaranun, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261930-e0261930
Open Access | Times Cited: 29
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
Xuemei He, Cai He, Weiqi Hong, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 932-971
Open Access | Times Cited: 17
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants
Irina Kislaya, Eduardo Freire Rodrigues, Vítor Borges, et al.
Emerging infectious diseases (2021) Vol. 28, Iss. 2, pp. 331-337
Open Access | Times Cited: 35
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz, et al.
Eurosurveillance (2022) Vol. 27, Iss. 21
Open Access | Times Cited: 21
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness
Alexandra F. Dalton, Zachary A. Weber, Katie Allen, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 9, pp. 1615-1625
Open Access | Times Cited: 10
Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium
Pierre Hubin, Laura Van den Borre, Toon Braeye, et al.
Vaccine X (2024) Vol. 18, pp. 100496-100496
Open Access | Times Cited: 3
COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
Jong‐Hoon Lee, Badar Kanwar, Asif Khattak, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13260-13260
Open Access | Times Cited: 16
Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
Haruka Maeda, Nobuo Saito, Ataru Igarashi, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 11, pp. 1971-1979
Open Access | Times Cited: 14
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study
Anna Ostropolets, George Hripcsak
BMJ Open (2022) Vol. 12, Iss. 8, pp. e061126-e061126
Open Access | Times Cited: 13
Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies
Shuailei Chang, Hongbo Liu, Jian Wu, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 469-469
Open Access | Times Cited: 12
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Lanièce Delaunay, Clara Mazagatos, Iván Martínez‐Baz, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2419258-e2419258
Open Access | Times Cited: 2
SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
Spyros Charonis, Lisa M. James, Apostolos P. Georgopoulos
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review
Miceline Mésidor, Yan Liu, Denis Talbot, et al.
Vaccine (2023) Vol. 42, Iss. 5, pp. 995-1003
Closed Access | Times Cited: 6
Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada
Jacques Pépin, Annie‐Claude Labbé, Alex Carignan, et al.
Vaccine (2021) Vol. 39, Iss. 50, pp. 7300-7307
Open Access | Times Cited: 15
COVID-19 pandemic in prisons in Spain: characteristics of cases and implemented control measures, March 2020–June 2022
Víctoria Hernando, Isabel Vázquez, Asunción Díaz, et al.
Public Health (2023) Vol. 218, pp. 45-52
Open Access | Times Cited: 5
Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs
Irina Kislaya, Eduardo Freire Rodrigues, Vítor Borges, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top